SS 18 - Lung 2: Small Cell Lung Cancer

Presentations

• 10:45am - 12:00pm PT

  Lung 2: Small Cell Lung Cancer

  Speaker: Daphna Gelblum, MD, MS - Memorial Sloan Kettering Cancer Center, West Harrison
• 10:45am - 12:00pm PT

  Lung 2: Small Cell Lung Cancer

  Speaker: Andreas Rimner, MD - Memorial Sloan Kettering Cancer Center, New York
• 10:45am - 10:55am PT

  Contralateral Esophageal-Sparing Technique Reduces High-Grade Esophagitis in Locally Advanced Small Cell Lung Cancer: Updated Results from a Randomized Trial

  Speaker: Yaping Xu, PhD - Shanghai Pulmonary Hospital, Shanghai
• 10:55am - 11:05am PT

  Anlotinib Combined with Whole-Brain Radiotherapy for Brain Metastases in Patients Diagnosed with Small Cell Lung Cancer: A Single-Arm, Phase 2 Trial

  Speaker: Lei Deng, - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy, Beijing
• 11:05am - 11:15am PT

  Durable Survival and Updated Safety of TQB2450 plus Anlotinib Maintenance Therapy in Limited-Stage Small Cell Lung Cancer: Extended Follow-Up from a Prospective Phase Ib Trial

  Speaker: Xiangjiao Meng, - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan
• 11:15am - 11:25am PT

  Real-World Results Comparing Treatment Outcomes: Once or Twice Daily Thoracic Radiotherapy in Younger and Older Patients with Limited-Stage Small Cell Lung Cancer

  Speaker: Jose Belderbos, MD, PhD - Netherlands Cancer Institute, Amsterdam
• 11:25am - 11:35am PT

  Prevention of Myelosuppression Associated with Concurrent Chemoradiotherapy in Limited Stage Small Cell Lung Cancer

  Speaker: Rinrong Lian, - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy, Beijing
• 11:35am - 11:45am PT

  Adebrelimab and Linperlisib for Patients with Limited-Stage Small-Cell Lung Cancer after Concurrent Chemoradiotherapy: A Phase I Trial

  Speaker: Ming Chen, MD - Sun Yat-Sen University Cancer Center, Guang Dong Province
• 11:45am - 11:55am PT

  Analysis of Progressive Patterns after First-Line Chemoimmunotherapy with or without Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer

  Speaker: Jing Feng, - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan